Safety and Efficacy of Eculizumab in High-risk TA-TMA

NCT07707687 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Transplant-Associated Thrombotic Microangiopathy (TA-TMA)

Interventions

DRUG: Eculizumab

Sponsor

First Affiliated Hospital of Zhejiang University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]